4Vilkin A,Nudelman I,Morgenstem S ,et al. Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation[J]. Dig Dis Sci ,2007,52(7) :1613-1620.
8Cheon YK, Lehman GA. Identification of risk factors for stone re- currence after endoscopic treatment of bile duct stones [ J ]. Eur J Gastroenterol Hepato1,2006,18 ( 5 ) :461-464.
4Alpini G,Philips JO,Benjamin,et al.Recent advance in the isolation of liver cells[J].Hepatology,1994,20:494.
5Kang-Jey Ho.Gallstone Characteristics,Surgical Incidence,Bile Lipid Composition,and Role of β-Glcuuronidase[J].Digestive Diseases and Sciences,1995,40:1 963.
6Shoda J,Tanaka N,He B,et al.Alterations of bile acid composition in gallstones,bile and live of patients with hepatolithiesis and there etiological significante[J].Dig Dis Sci,1993,38(11):2 130.
7James F,Green RM,Rosenbluth AB,et al.Tumor Necrosis Factor-Alpha Decreases Hepatocyte Bile Salt Uptake and Mediates Endotoxin-Induced Cholestasis[J].Hepatology,1995,22(4):1 273.
8Chen Cy,Shiseh SC,Lin XZ,et a1.Biliary Sludge and pigment stone formation in bile duct-ligated guinea pigs[J].Dig Dis Sci,1999,44(1):203.
9Kim DI,Kim MH, Lee SK,et al. Risk factors for recurrence ofprimary bile duct stones after endoscopic biliary sphincterotomy.Gastrointest Endosc, 2001,54:4248.
10Pereira-Lima JC,Jakobs R,Winter UH,et al. Long-term results(7 to 10 years) of endoscopic papillotomy forcholedocholithiasis.Multivariate analysis of prognostic factors for therecurrence of bili-ary symptoms. Gastrointest Endosc,1998,48:457-464.
